Prospective Cohort Study of Patients With Infective Endocarditis at Pitié-Salpêtrière Hospital
NCT ID: NCT04992923
Last Updated: 2025-11-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
700 participants
OBSERVATIONAL
2020-09-15
2041-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In order to improve the management and the prognosis of IE, clinical data from larges prospective cohort studies are needed.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prognosis and Management of Infective Endocarditis Using the Clinical Data Warehouse From AP-HP
NCT06957119
Characterization of Endocarditis to Streptococci and Impact of the CMI on the Future of the Patients
NCT03306225
Belgian Infective Endocarditis Registry
NCT06745440
The Value of 99mTc-Leukoscan® Scintigraphy in the Diagnosis of Infectious Endocarditis on Surgical Materials
NCT03112356
Evaluation of Systemic Microvascular Endothelial Dysfunction in Patients Presenting With Infective Endocarditis
NCT02940340
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The characteristics of the patients (demographics, clinical, laboratory, and imaging data) at the time of IE diagnosis and during the follow-up will be collected. The patients will be followed up to 10 years after inclusion.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nadjib Hammoudi, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Pitié-Salpêtrière Hospital (AP-HP)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
APHP Pitié-Salpêtrière Hospital, Department of Cardiology
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APHP200685
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.